| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/20/2009 | WO2008089094A9 Non-simian cells for growth of porcine reproductive and respiratory syndrome (prrs) virus |
| 08/20/2009 | US20090210966 rice blast susceptibility gene pi21, resistance gene pi21 and uses thereof |
| 08/20/2009 | US20090210954 Genes |
| 08/20/2009 | US20090210951 Avian transgenesis using an ovalbumin nucleotide sequence |
| 08/20/2009 | US20090209732 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same |
| 08/20/2009 | US20090209463 Hgf Precursor Protein Variant and Active Protein Thereof |
| 08/20/2009 | US20090209452 Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5 |
| 08/20/2009 | US20090209006 Taci-immunoglobulin fusion proteins |
| 08/20/2009 | US20090209005 Chimeric dna polymerase |
| 08/20/2009 | US20090209004 Human il-1 beta antagonists |
| 08/20/2009 | US20090209003 Mutant pcna |
| 08/20/2009 | US20090209002 Compositions and methods relating to cellular targeting |
| 08/20/2009 | US20090209001 2-Deoxy-D-Ribose 5-Phosphate Aldolases (DERAS) And Uses Thereof |
| 08/20/2009 | US20090209000 Genetically Programmed Expression of Proteins |
| 08/20/2009 | US20090208995 Pro-clotting enzyme, and method for detection of endotoxin or (1-3)-beta-d-glucan using the same |
| 08/20/2009 | US20090208972 Cytotoxic protein and utlization thereof |
| 08/20/2009 | US20090208949 Phosphatidylinositol phosphate kinase type i gamma splice variants as biomarkers and drug targets for epithelial cancers |
| 08/20/2009 | US20090208938 Use of the MCM8 Gene for the Preparation of a Pharmaceutical Composition |
| 08/20/2009 | US20090208537 Anti-Neovasculature Preparations for Cancer |
| 08/20/2009 | US20090208530 HIV polynucleotides and polypeptides derived from Botswana MJ4 |
| 08/20/2009 | US20090208529 Recombinant Novirhabdoviruses and Uses Thereof |
| 08/20/2009 | US20090208528 Empty capsids (vlps(-vp4)) of the infectious bursal disease virus (ibdv), obtainment process and applications |
| 08/20/2009 | US20090208522 Neutralizing Epitope-Based Growth Enhancing Vaccine |
| 08/20/2009 | US20090208504 Polypeptides involved in immune response |
| 08/20/2009 | US20090208502 Apoptosis-inducing protein complexes and therapeutic use thereof |
| 08/20/2009 | US20090208500 Method of producing antibodies with improved function |
| 08/20/2009 | US20090208477 Production of high mannose proteins in plant culture |
| 08/20/2009 | US20090208475 Mina53 assays |
| 08/20/2009 | US20090208474 Biological entities and the use thereof |
| 08/20/2009 | US20090208460 Mutant Herpes Simplex Viruses Comprising Nucleic Acid Encoding A Nitroreductase |
| 08/20/2009 | US20090208459 Methods of treating anemia using recombinant adeno-associated virus virions |
| 08/20/2009 | US20090208454 Modified interferon beta polypeptides and their uses |
| 08/20/2009 | US20090208447 Polypeptides |
| 08/20/2009 | US20090208440 Biological entities and the use thereof |
| 08/20/2009 | CA2714657A1 Anti-adam-15 antibodies and utilization of the same |
| 08/20/2009 | CA2714585A1 Enzymatic conjugation of bioactive moieties |
| 08/20/2009 | CA2714155A1 Fish protein hydrolysate having a bone-stimulating and -maintaining activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same |
| 08/20/2009 | CA2714128A1 Fish protein hydrolysate having a satietogenic activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same |
| 08/19/2009 | EP2090657A2 Anti-IL-12 antibodies, compositions, methods and uses |
| 08/19/2009 | EP2090656A1 Mutant androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof |
| 08/19/2009 | EP2090590A1 Antibody against aflatoxins, support using the antibody, method of immunologically detecting aflatoxins and method of concentrating and purifying aflatoxins |
| 08/19/2009 | EP2090589A1 Albumin-fused Kunitz domain peptides |
| 08/19/2009 | EP2090585A1 Antigenic polypeptide usable as therapeutic agent for malignant neoplasm |
| 08/19/2009 | EP2089514A1 Cancerous disease modifying antibodies |
| 08/19/2009 | EP1735337B1 Method of producing highly pure teicoplanin |
| 08/19/2009 | EP1497467B1 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof |
| 08/19/2009 | EP1432793B1 Aminopeptidase b2324 |
| 08/19/2009 | EP1343909B1 Methods for large scale production of kringle 2 plus serine protease domain (k2s) of plasminogen in prokaryotes |
| 08/19/2009 | EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/19/2009 | EP1187918B9 Tek antagonists |
| 08/19/2009 | EP0942987B1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 08/19/2009 | CN101512336A Stimulation of pancreatic beta cell proliferation |
| 08/19/2009 | CN101512008A Interleukin-13 binding proteins |
| 08/19/2009 | CN101512007A Methods and compositions for use in treatment of patients with autoantibody positive diseases |
| 08/19/2009 | CN101511997A Methods for producing secreted polypeptides having biological activity |
| 08/19/2009 | CN101511994A Protein production using eukaryotic cell lines |
| 08/19/2009 | CN101511870A Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 08/19/2009 | CN101511869A Anti-MCP-1 antibodies, compositions, methods and uses |
| 08/19/2009 | CN101511373A Modified factor VIII and factor IX genes and vectors for gene therapy |
| 08/19/2009 | CN101509031A Method for preparing short and naked dinoflagellate toxin monoclone antibody |
| 08/19/2009 | CN101509030A Hydrolyzation of pig blood with complex enzyme method for producing blood peptide native |
| 08/19/2009 | CN101509029A Method for accelerating production of rapeseed peptide with enzyme hydrolysis of rapeseed dregs by using sodium sulfite |
| 08/19/2009 | CN101509011A Carrier containing immunoglobulinlg gene, construction method and uses thereof |
| 08/19/2009 | CN101509002A Recombinant rubella virus protein and uses thereof |
| 08/19/2009 | CN101508999A Recombinant toxoplasma protein and uses thereof |
| 08/19/2009 | CN101508994A Gene optimization and high-efficiency expression of recombinant human interferon a2b |
| 08/19/2009 | CN101508734A Anti-CD40 monoclonal antibody |
| 08/19/2009 | CN100529096C Methods for producing polypeptides in aspergillus mutant cells |
| 08/19/2009 | CN100529080C Bacterial insecticidal proteins |
| 08/19/2009 | CN100529074C Therapeutic binding molecules |
| 08/19/2009 | CN100528357C Novel supported catalyst systems |
| 08/19/2009 | CN100528235C Conjugates of erythropoietin |
| 08/18/2009 | US7576258 Transgenic transchromosomal rodents for making human antibodies |
| 08/18/2009 | US7576193 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 08/18/2009 | US7576190 Fibroblast growth factor 21 compounds fused to proteins that have the effect of extending the in vivo half-life of the polypeptides; these fusion proteins can be used to treat non-insulin dependent diabetes mellitus, obesity and metabolic syndrome |
| 08/18/2009 | US7576189 antibodies against such VEGFs, which may be used to inhibit their action, for example, to inhibit the growth of tumors, to treat diabetic retinopathy, rheumatoid arthritis and psoriasis |
| 08/18/2009 | US7576184 Monoclonal antibody for use in detection of plant protein associated with natural rubber; diagnosing latex allergies and hypersensitivity |
| 08/18/2009 | US7576182 Compositions and methods for the treatment of immune related diseases |
| 08/18/2009 | US7576179 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 08/18/2009 | US7576178 DADD, death activator death domain protein |
| 08/18/2009 | US7576176 Neisseria meningitidis antigens and compositions |
| 08/18/2009 | US7575923 CD19xCD3 specific polypeptides and uses thereof |
| 08/18/2009 | US7575922 Polypeptide and gene encoding the same |
| 08/18/2009 | US7575899 Has an inactivated inherent NCgl2053 dehydrogenase gene; by using the microorganism, the yield of L-lysine is increased since an inherent NCgl2053 dehydrogenase gene is inactivated; L-lysine can be produced with high yield |
| 08/18/2009 | US7575898 Comprises nucleotide sequences coding zein and therapeutic proteins for expression in plants; bioreactors; gene therapy |
| 08/18/2009 | US7575897 Using blood coagulation factor to treat bleeding disorders; enhancing furin expression in cells |
| 08/18/2009 | US7575896 Fusing monoclonal antibody-producing cell with an immortal cell to produce hybridoma; diagnosis and treatment of infection and metabolic disorders |
| 08/18/2009 | US7575895 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof |
| 08/18/2009 | US7575894 Human recombinant beta-interferon with improved solubility |
| 08/18/2009 | US7575891 Process for production of diphtheria toxin |
| 08/18/2009 | US7575885 Tyrosylprotein sulfotransferases and methods of use thereof |
| 08/18/2009 | US7575879 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; bradycardial agents; identification and preparation of vascular endothelial growth factor-E (VEGF-E), a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1 |
| 08/18/2009 | US7575872 An antibody specific for von Willebrand factor specific cleaving enzyme (hereinafter also referred to as ADAMTS-13), which can be obtained from a warm-blooded animal immunized and sensitized with a polypeptide containing a part or the whole of ADAMTS-13 amino acid sequence |
| 08/18/2009 | US7575752 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 08/18/2009 | US7575749 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 08/18/2009 | US7575746 anticarcinogenic; antibody or antigen-binding portion that specifically binds to human insulin-like growth factor I receptor; comprises: light and heavy chain region with frameworks mutations reverted back to amino acid sequence encoded by germ line A30 and DP35 genes; genetic engineering |
| 08/18/2009 | CA2413156C Expression vectors |
| 08/18/2009 | CA2230240C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 08/18/2009 | CA2105552C Soluble ligands for cd40 |
| 08/13/2009 | WO2009099678A1 Influenza b vaccines |